Risk communication in consultations about hormone therapy in the menopause:: concordance in risk assessment and framing due to the context

被引:8
|
作者
Hoffmann, M.
Hammar, M.
Kjellgren, K. I.
Lindh-Astrand, L.
Ahlner, J.
机构
[1] Linkoping Univ, Div Clin Pharmacol, Dept Med & Care, Fac Hlth Sci, Linkoping, Sweden
[2] Linkoping Univ, Dept Obstet & Gynecol, Dept Mol & Clin Med, Fac Hlth Sci, Linkoping, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Nursing, Fac Hlth & Caring Sci, Gothenburg, Sweden
[4] Nalt Board Forens Med, Dept Forens Chem, Linkoping, Sweden
关键词
risk; risk assessment; communication; physician-patient relations; professional-patient relations;
D O I
10.1080/13697130600870220
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background It is important for the physician and the patient to have a mutual understanding of the possible consequences of different treatment alternatives in order to achieve a partnership in decision-making. Objective The aim of this study was to explore to which degree first-time consultations for discussion of climacteric discomfort achieved shared understanding of the risks and benefits associated with hormone therapy in the menopausal transition. Methods Analysis of structure and content of transcribed consultations (n=20), and follow-up interviews of the women (n=19 pairs of consultations and interviews), from first-time visits for discussion of climacteric discomfort and/or HT with five physicians at three different outpatient clinics of gynecology in Sweden. Results Four distinctively different interpretations of risk, depending on whether or not benefits were discussed in the same context, emerged from the analysis. On average, five advantages (range 0-11) and two (0-3) disadvantages were mentioned during the consultations. In the interviews, the women expressed on average four advantages (0-7) and one disadvantage (0-3). There were major variations between advantages and disadvantages expressed in the consultation and the following interview. Conclusion Even though the consultations scored high in patient involvement, the information in most consultations was not structured in a way that made it possible to achieve a shared or an informed decision-taking.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 50 条
  • [41] The association between early menopause and risk of ischaemic heart disease: Influence of Hormone Therapy
    Lokkegaard, E
    Jovanovic, Z
    Heitmann, BL
    Keiding, N
    Ottesen, B
    Pedersen, AT
    MATURITAS, 2006, 53 (02) : 226 - 233
  • [42] Re: Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
    Grant, Ellen C. G.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (13) : 1069 - 1069
  • [43] Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw, J. E.
    Prentice, R. L.
    Manson, J. E.
    Wu, L.
    Barad, D.
    Barnabei, V. M.
    Ko, M.
    LaCroix, A. Z.
    Margolis, K. L.
    Stefanick, M. L.
    JOURNAL OF WOMENS HEALTH, 2007, 16 (06) : 927 - 928
  • [44] Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause
    Staller, Kyle
    Townsend, Mary K.
    Khalili, Hamed
    Mehta, Raaj
    Grodstein, Francine
    Whitehead, William E.
    Matthews, Catherine A.
    Kuo, Braden
    Chan, Andrew T.
    GASTROENTEROLOGY, 2017, 152 (08) : 1915 - +
  • [45] Assessment of a visual risk communication aid used to support patients with psoriasis in deciding about biological therapy
    Dolan, M.
    Connolly, M.
    Tobin, A. M.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (05) : 594 - 596
  • [46] Postmenopausal hormone therapy and risk of venous thromboembolism: what about progesterone?
    Scarabin, Pierre-Yves
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 364
  • [47] Hormone replacement therapy and risk of atrial fibrillation in Taiwanese menopause women: A nationwide cohort study
    Wei-Chung Tsai
    Yaw-Bin Haung
    Hsuan-Fu Kuo
    Wei-Hua Tang
    Po-Chao Hsu
    Ho-Ming Su
    Tsung-Hsien Lin
    Chih-Sheng Chu
    Shih-Jie Jhuo
    Kun-Tai Lee
    Sheng-Hsiung Sheu
    Chung-Yu Chen
    Ming-Tsang Wu
    Wen-Ter Lai
    Scientific Reports, 6
  • [48] Age at menopause and hormone replacement therapy as risk factors for head and neck and oesophageal cancer (Review)
    McCarthy, Caroline E.
    Field, John K.
    Marcus, Michael W.
    ONCOLOGY REPORTS, 2017, 38 (04) : 1915 - 1922
  • [49] Hormone replacement therapy and risk of atrial fibrillation in Taiwanese menopause women: A nationwide cohort study
    Tsai, Wei-Chung
    Haung, Yaw-Bin
    Kuo, Hsuan-Fu
    Tang, Wei-Hua
    Hsu, Po-Chao
    Su, Ho-Ming
    Lin, Tsung-Hsien
    Chu, Chih-Sheng
    Jhuo, Shih-Jie
    Lee, Kun-Tai
    Sheu, Sheng-Hsiung
    Chen, Chung-Yu
    Wu, Ming-Tsang
    Lai, Wen-Ter
    SCIENTIFIC REPORTS, 2016, 6
  • [50] Stroke risk in women: the role of menopause and hormone therapy (vol 11, pg 82, 2012)
    Lisabeth, L.
    Bushnell, C.
    LANCET NEUROLOGY, 2012, 11 (02): : 125 - 125